ARYx Therapeutics
Latest round
- Series E
Last raised
- Jan 2006
Total raised
- $110M
Investors
- 11
About ARYx Therapeutics
ARYx Therapeutics Inc.Founded in 1997 and headquartered in Fremont, US, ARYx Therapeutics Inc. specializes in biotechnology. It has undergone significant changes in its business strategy over time.ARYx Therapeutics Inc. is dedicated to developing therapeutic solutions that address unmet medical needs. Its portfolio includes advanced drug formulations targeting specific health issues, with a focus on enhancing patient treatment efficacy.00, with an EBITDA reflecting a loss of USD 29,751,000.ARYx Therapeutics Inc. has ceased operations, and as such, no future growth plans or new product launches are currently being pursued.
Who invested in ARYx Therapeutics
11 investors across 3 rounds
See all investors in ARYx Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about ARYx Therapeutics
Who invested in ARYx Therapeutics?
ARYx Therapeutics has 11 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has ARYx Therapeutics raised?
ARYx Therapeutics has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did ARYx Therapeutics last raise money?
ARYx Therapeutics's most recent round on record is a Series E, in Jan 2006.
What does ARYx Therapeutics do?
ARYx Therapeutics is a biotechnology company.
Where is ARYx Therapeutics headquartered?
ARYx Therapeutics is headquartered in Fremont, US.
Which VCs invest in companies like ARYx Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at ARYx Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series E
Raising like ARYx Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.